Details
Zusammenfassung: <jats:title>Key Points</jats:title> <jats:p>Patient-derived iPSCs recapitulate juvenile myelomonocytic leukemia. MEK inhibition normalizes GM-CSF independence and hypersensitivity in myeloid precursors from JMML iPSCs.</jats:p>
Umfang: 4925-4929
ISSN: 0006-4971
1528-0020
DOI: 10.1182/blood-2013-01-478412